Ophthalmologic findings in Fabry disease patients: relation to disease severity and to enzyme replacement therapy in a Mexican family

被引：0
|
作者：
Borja-Borja, Araceli [1 ]
Salas-Perez, Gabriela [1 ]
Gutierrez-Ponce, Jorge [1 ]
Sanchez-Acosta, Antonio [1 ]
Radillo-Diaz, Pablo [2 ]
Sierra, Fatima [3 ]
Garcia-Perez, Juan C. [4 ]
机构：
[1] Hosp Especialidades Puebla, Puebla, Mexico
[2] Ctr Med Coyoacan, Mexico City, DF, Mexico
[3] Hosp Mujer SSA, Puebla, Puebla, Mexico
[4] Hosp Univ Popular Estado Puebla, Puebla, Mexico
来源：
MOLECULAR GENETICS AND METABOLISM | 2017年 / 120卷 / 1-2期
关键词：
D O I：
10.1016/j.ymgme.2016.11.049
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [21] Renal function in patients with fabry disease on enzyme replacement therapy (ERT)
    West, Michael
    Cybulla, Markus
    Feriozzi, Sandro
    Schwarting, Andreas
    Schiffmann, Raphael
    Mehta, Atul
    Sunder-Plassmann, Gere
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 13 - 13
  • [22] Effect of enzyme replacement therapy on clinical outcome in patients with Fabry disease
    Breunig, FB
    Knoll, A
    Weidemann, F
    Strotmann, J
    Wanner, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V246 - V247
  • [23] Looking for predictors of mortality in patients with Fabry disease on enzyme replacement therapy
    Reisin, Ricardo
    Ferrari, Gustavo
    Kisinovsky, Isaac
    Neumann, Pablo
    Caceres, Guillermo
    Azcurra, Zulema
    Gastaldi, Anibal
    Palombo, Marina
    Choua, Martin
    Forrester, Mariano
    Cedrolla, Martin
    Antongiovanni, Norberto
    Fernandez, Segundo
    Dupuy, S.
    Amartino, Hernan M.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S99 - S100
  • [24] Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease
    Kosch, M
    Koch, HG
    Oliveira, JP
    Soares, C
    Bianco, F
    Breuning, F
    Rasmussen, Å
    Schaefer, RM
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 1279 - 1282
  • [25] ENZYME REPLACEMENT THERAPY STABILIZES QUALITY OF LIFE IN PATIENTS WITH FABRY DISEASE
    Kantola, I.
    Hietaharju, A.
    Taurio, J.
    Kananen, K.
    Peschek, T.
    Tarusalo, T.
    Kantola, T.
    Viikari, J.
    CLINICAL THERAPEUTICS, 2009, 31 : S42 - S42
  • [26] IMPACT OF SWITCHING ENZYME REPLACEMENT THERAPY ON PATIENTS AFFECTED BY FABRY DISEASE
    Jovanovic, A.
    Sharma, R.
    Kempshall, S.
    Thompson, L.
    Bleakley, C.
    Bell, L.
    Taylor, R.
    Whitby, J.
    Smith, E.
    Meehan, M.
    Hill, A.
    Hendriksz, C. J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S146 - S146
  • [27] Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease
    Oder, Daniel
    Nordbeck, Peter
    Wanner, Christoph
    NEPHRON, 2016, 134 (01) : 30 - 36
  • [28] Effect of Enzyme Replacement Therapy on Diastolic Function in Patients With Fabry Disease
    Kim, Minjeong
    Seo, Jiwon
    Cho, Iksung
    Ha, Jong-Won
    Shim, Chi Young Y.
    Hong, Geu-Ru
    CIRCULATION, 2023, 148
  • [29] EFFECT OF ENZYME REPLACEMENT THERAPY ON ENDOTHELIAL FUNCTION IN PATIENTS WITH FABRY DISEASE
    Cokan, Andreja
    Rainer, Sasa
    Vujkovac, Bojan
    Verovnik, Franc
    Benko, Davorin
    Sabovic, Miso
    NEPHROLOGY, 2005, 10 : A227 - A228
  • [30] Enzyme replacement therapy in Fabry disease should be started in patients with microalbuminuria
    Lin, C-Y
    Lee, N-C
    Niu, D-M
    Ng, Y-Y
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 47 - 47
12345